Sangamo Therapeutics, Inc. Common Stock
Symbol: SGMO (NASDAQ)
0.52
▲ (0.06%) 0.000
Company Description:
Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the Priority Neurology Pipeline offers Chronic Neuropathic Pain, Prion Disease, and Neurology; Partnered Programs offer Hemophilia A, Oncology, ALS/FTD, and Huntington's Disease; and Other Pipelines include Fabry Disease, Renal Transplant, Inflammatory Bowel Disease, and Multiple Sclerosis.
Key Stats
- Today's Open: $0.52
- Today's High: $0.547
- Today's Low: $0.518
- Today's Volume: 2.68M
- Yesterday Close: $0.5197
- Yesterday High: $0.54
- Yesterday Low: $0.5101
- Yesterday Volume: 2.98M
- Last Min Volume: 0
- Last Min High: $0.523
- Last Min Low: $0.52
- Last Min VWAP: $0
Company Profile
- Name: Sangamo Therapeutics, Inc. Common Stock
- Website: https://www.sangamo.com
- Listed Date: 2000-04-06
- Location: RICHMOND, CA
- Market Status: Active
- CIK Number: 0001001233
- SIC Code: 2836
- SIC description: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
- Market Cap: $158.40M
- Round Lot: 100
- Outstanding Shares: 301.71M
- Asset Type: CS
RECENT FILINGS FOR SGMO
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-09-04 | 8-K | View |
| 2025-08-26 | 4 | View |
| 2025-08-26 | 4 | View |
| 2025-08-26 | 4 | View |
| 2025-08-26 | 4 | View |
| 2025-08-26 | 4 | View |
| 2025-08-08 | S-8 | View |
| 2025-08-07 | 10-Q | View |
| 2025-08-07 | 8-K | View |
| 2025-07-24 | 4 | View |
| 2025-07-24 | 4 | View |
| 2025-07-24 | 4 | View |
| 2025-07-24 | 4 | View |
| 2025-07-24 | 4 | View |
| 2025-06-24 | 8-K | View |
| 2025-06-16 | 8-K | View |
| 2025-06-16 | 4 | View |
| 2025-06-16 | 4 | View |
| 2025-06-16 | 4 | View |
| 2025-06-16 | 4 | View |
Latest News on SGMO